Navigation Links
Arena Pharmaceuticals Announces Third Quarter 2010 Financial Results and Reviews Recent Developments
Date:11/9/2010

na's forward-looking statements are disclosed in Arena's filings with the Securities and Exchange Commission. These forward-looking statements represent Arena's judgment as of the time of this release. Arena disclaims any intent or obligation to update these forward-looking statements, other than as may be required under applicable law.Contact: Arena Pharmaceuticals, Inc.

Media Contact: Russo PartnersJack Lief

David Schull, PresidentPresident and CEO

david.schull@russopartnersllc.com858.717.2310Cindy McGeeManager, IR and Corporate Communications

Anthony J. Russo, Ph.D., CEO858.453.7200, ext. 1479

tony.russo@russopartnersllc.com212.845.4251 www.arenapharm.com Arena Pharmaceuticals, Inc.Condensed Consolidated Statements of Operations (In thousands, except per share amounts)Three months endedNine months endedSeptember 30,September 30,2010200920102009(unaudited)(unaudited)RevenuesManufacturing services

$  1,846$  1,737$  5,258$  4,663Collaborative agreements

5,7838827,3433,042  Total revenues

7,6292,61912,6017,705Operating ExpensesCost of manufacturing services

1,8141,7055,3094,702Research and development

20,15522,14758,97188,972General and administrative

6,8625,42320,63618,725Restructuring charges

———3,324Amortization of acquired technology & other intangibles

5415821,6091,721  Total operating expenses

29,37229,85786,525117,444Interest and Other Income (Expense)Interest income

10775338291Interest expense

(6,267)(7,339)(16,198)(10,991)Gain from valuation of derivative liabilities

3,0232,4724,857345Loss on extinguishment of debt

(12,354)(2,479)(12,354)(2,479)Other

968(326)988(859)  Total interest and other expense, net

(14,523)(7,597)(22,369)(13,693)Net loss

$(36,
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Arena Pharmaceuticals Provides Update on GPR119 Portfolio for Type 2 Diabetes
2. Endologix Announces Publication of Clinical Trial Results Supporting Anatomical Fixation with a Suprarenal Aortic Extension
3. Arena and Eisai Announce Upcoming Lorcaserin Presentations at Obesity 2010
4. Arena and Eisai Provide Update on Lorcaserin FDA Advisory Committee Meeting
5. Arena Pharmaceuticals to Host Conference Call and Webcast Following Lorcaserin FDA Advisory Committee Meeting
6. Arena Pharmaceuticals Submits New Drug Application to FDA for Lorcaserin for Weight Management
7. Published Data Demonstrate Arena Pharmaceuticals Lorcaserin Has Low Abuse Potential
8. Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments
9. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Tuesday, November 10, 2009
10. Arena Pharmaceuticals Lorcaserin to be Featured in Multiple Presentations at Obesity 2009
11. Arena Pharmaceuticals Reports Positive, Highly Significant BLOSSOM Trial Results for Weight Management; NDA Submission on Track for December
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... 23, 2014  The American Diabetes Association is ... for people with diabetes and that all people ... of statins, in keeping with recent changes to ... American College of Cardiology (ACC) and American Heart ... most recent changes to the Association,s annual revised ...
(Date:12/24/2014)... , Dec. 23, 2014  Medical Science Liaisons ... the key link between the medical device industry and ... more in the coming years as the device industry ... According to research by benchmarking firm, Best Practices, ... gain an important edge is by harnessing new technology ...
(Date:12/22/2014)... 22, 2014 Research and Markets ( ... "US Self-monitoring Blood Glucose Market" report to their ... This market insight focuses on the developments in ... United States . Reimbursement analysis and the effects ... for more than 73 SMBG meters have been performed, ...
Breaking Medicine Technology:New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 2New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 3New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 4Role of Medical Science Liaisons Evolving in Medical Device Sector 2US Self-monitoring Blood Glucose Market 2
... Calif., Oct. 21 IRIDEX Corporation (Nasdaq: ... Modular Multi-Wavelength laser photocoagulator solution, which will be ... Ophthalmology meeting in San Francisco. , ... compete in the multi-wavelength photocoagulator market segment with ...
... PARK, Ill., Oct. 20 Abbott (NYSE: ABT ... of privately held eye care company Visiogen, expanding the ... lens (IOL) technology to address presbyopia for cataract patients. ... significant advancement in artificial lens technology. It is ...
Cached Medicine Technology:IRIDEX Introduces Modular Multi-Wavelength Laser Solution at the American Academy of Ophthalmology 2Abbott Completes Visiogen Acquisition 2
(Date:12/25/2014)... “Every three months the trends for evening dresses ... be one of the hottest styles in the next few ... company releases 26 A-line sweetheart evening dresses, and announces the ... “We are trying our best to help a lady to ... with affordable prices, we provide discounted delivery costs to our ...
(Date:12/25/2014)... Recently, BellasDress has launched its ... dresses. BellasDress has chosen their best-selling lace wedding dresses, ... the holiday season. , Now, BellasDress.com features popular ... here at discount prices. The business hopes everyone can ... , “All our elegant products are made ...
(Date:12/25/2014)... (PRWEB) December 25, 2014 Recently, LunaDress.co.uk has updated ... dresses and related accessories. Now, all of the models at LunaDress.co.uk ... moment a groom lifts the wedding veil can turn out to ... stunning charm. A wedding veil can always bring surprise to a ... suggestions on how to choose veils for a big day ...
(Date:12/25/2014)... 24, 2014 (HealthDay News) -- Among early stage breast ... than half of one percent will eventually develop leukemia ... reveals. The finding comes from a review of ... and 2007, and it suggests that the risk for ... experts had previously thought. "The frequency of bone ...
(Date:12/25/2014)... (PRWEB) December 25, 2014 “ SmileStix ” ... which features the latest and coolest mobile applications on the ... expert and host of NewsWatch, conducted the app review and ... to create personal stickers. , The old saying goes, “A ... lot of words that can describe a single image, because ...
Breaking Medicine News(10 mins):Health News:BellasDress.com’s Christmas Sale: Trendy Wedding Dresses With Big Discounts 2Health News:LunaDress Provides Professional Tips On Shopping Wedding And Prom Dresses 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 3Health News:An Application to Create Custom Stickers was Featured on NewsWatch Television on December 19, 2014 2
... measure their peak heart rates for exercise will need to do ... A new formula based on a large study from ... rate a healthy woman should attain during exercise. It also will ... test. "Now we know for the first time ...
... new study of nearly 8,800 women with early-stage breast ... percent completed their full regimen of hormone therapy ... women were particularly likely to discontinue treatment. The findings ... behind such treatment non-compliance and also develop interventions to ...
... It,s time to ... are teaming up to reach Physical Education students by utilizing the dynamic media + digital ... weights. , ... and Austin, TX (PRWEB) June 29, 2010 -- Hyper Wear, LLC, a fitness, health and ...
... ... solutions for healthcare organizations, adds a New Vice President to head Client Services, Sandra ... (PRWEB) ... to Vice President of Client Services and Strategy. Fancher will work closely with our ...
... ... set to give insights on how to achieve female six pack abs in no ... Abs by Mike Geary may just be the book to read. If you are ... many instruction manuals, books and DVDs flooding the fitness market which do not offer ...
... ... Meer looks back to a six year success story as a national ... Germany. Furthermore since 2004 more and more requests have been received from ... get more and more shipped to the UK, USA and even Australia.,Strandkorb ...
Cached Medicine News:Health News:New formula gives first accurate peak heart rate for women 2Health News:Fewer than half of breast cancer patients adhere to hormonal therapy regimen, study finds 2Health News:Fewer than half of breast cancer patients adhere to hormonal therapy regimen, study finds 3Health News:HOPSports, Inc. Adds SandBell to Award-Winning Training System 2Health News:HOPSports, Inc. Adds SandBell to Award-Winning Training System 3Health News:MedTouch Makes Senior Staff Appointment 2Health News:Book Reveals the Truth about Six Pack Abs 2Health News:Strandkorb & Meer Going to Exceed 20% of Total Sales Volume with International Business in 2010 2Health News:Strandkorb & Meer Going to Exceed 20% of Total Sales Volume with International Business in 2010 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: